These successful investors, innovators and executives will share insights on identifying, funding and advancing new therapies that will transform the treatment of respiratory diseases.
Craig S. Conoscenti, MD, FCCP, ATSF
Medical Expert, Interstitial Lung Disease
Boehringer Ingelheim Pharmaceuticals
Erik Folch, MD, MSc
Chief, Complex Chest Disease Center
Massachusetts General Hospital, Harvard Medical School
Heidi Mansour, PhD, RPh
Associate Professor
The University of Arizona Colleges of Pharmacy & Medicine
Momen M. Wahidi, MD, MBA
Director, Interventional Pulmonology and Bronchoscopy
Duke University Health System
George Washko, Jr., MD
Pulmonologist, Division of Pulmonary and Critical Care Medicine
Brigham and Women's Hospital
Timothy Watkins, MD, MSc
Executive Director, Clinical Research, Respiratory Disease Area Lead Inflammation/Respiratory Therapeutic Area
Gilead Sciences
Eric White, MD
Professor of Internal Medicine, Division of Pulmonary and Critical Care Medicine
University of Michigan
